D. Bonanni

发表

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety

P. Circosta, B. Rolando, S. Al-Karadaghi, 2022, Journal of medicinal chemistry.

Development of machine learning classifiers to predict compound activity on prostate cancer cell lines

G. Rastelli, Luca Pinzi, D. Bonanni, 2022, Journal of Cheminformatics.

Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid.

W. Y. Wahlgren, Elisabetta Marini, S. Oliaro-Bosso, 2018, European journal of medicinal chemistry.

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety

P. Circosta, B. Rolando, S. Al-Karadaghi, 2021, Journal of medicinal chemistry.

Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.

P. Circosta, B. Rolando, S. Al-Karadaghi, 2018, Journal of medicinal chemistry.

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications

G. Rastelli, D. Moi, A. Citarella, 2021, ACS omega.

Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.

L. Chiarelli, M. Mori, F. Meneghetti, 2018, European journal of medicinal chemistry.

Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3.

W. Y. Wahlgren, Elisabetta Marini, B. Rolando, 2019, ACS medicinal chemistry letters.

Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring

G. Rastelli, D. Passarella, D. Moi, 2022, RSC advances.

Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.

S. Oliaro-Bosso, D. Boschi, M. Lolli, 2019, MedChemComm.

Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer.

G. Rastelli, S. Franchini, C. Imbriano, 2023, European journal of medicinal chemistry.

Dual Targeting Strategies On Histone Deacetylase 6 (HDAC6) And Heat Shock Protein 90 (Hsp90).

G. Rastelli, D. Moi, A. Citarella, 2021, Current Medicinal Chemistry.

Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.

Elisabetta Marini, C. Cena, D. Boschi, 2017, European journal of medicinal chemistry.

Computational Method for Structure-Based Analysis of SAR Transfer.

J. Bajorath, M. Lolli, D. Bonanni, 2020, Journal of medicinal chemistry.

Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.

Elisabetta Marini, C. Cena, D. Boschi, 2017, European journal of medicinal chemistry.

The University of Bradford Institutional Repository

C. Cena, D. Boschi, Annalisa Costale, 2022 .